Simcha Therapeutics Shares Data at AACR Annual Meeting Highlighting Potent Preclinical Efficacy of Decoy-Resistant IL-18 Cytokine

NK cells quickly become exhausted and lose efficacy when confronted with tumor cells deficient in MHC Class 1.